Paul Hjemdahl

Publications
CV
Public outreach and news

Articles

Article: AMERICAN HEART JOURNAL. 2024;269:118-130
Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention
Mazhar F; Hjemdahl P; Sjolander A; Kahan T; Jernberg T; Carrero JJ
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023;32(11):1223-1232
Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries
Komen JJ; Hunt NB; Pottegard A; Hjemdahl P; Wettermark B; Olesen M; Bennie M; Mueller T; Carragher R; Karlstad O; Kjerpeseth LJ; Klungel OH; Forslund T
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2023;81(3):307-317.e1
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
Trevisan M; Hjemdahl P; Clase CM; de Jong Y; Evans M; Bellocco R; Fu EL; Carrero JJ
Article: EUROPEAN HEART JOURNAL. 2022;43(37):3528-3538
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study
Komen JJ; Pottegard A; Mantel-Teeuwisse AK; Forslund T; Hjemdahl P; Wettermark B; Hallas J; Olesen M; Bennie M; Mueller T; Carragher R; Karlstad O; Kjerpeseth LJ; Klungel OH
Article: AMERICAN HEART JOURNAL. 2022;251:78-90
Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronar y hear t disease
Mazhar F; Hjemdahl P; Clase CM; Johnell K; Jernberg T; Carrero JJ
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2022;11(14):e025813
Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease
Mazhar F; Hjemdahl P; Clase CM; Johnell K; Jernberg T; Sjolander A; Carrero JJ
Article: HEART. 2022;108(8):613-618
Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
Komen J; Pottegard A; Hjemdahl P; Mantel-Teeuwisse AK; Wettermark B; Hellfritzsch M; Hallas J; Herings R; Smits L; Forslund T; Klungel O
Article: EUROPACE. 2021;23(11):1722-1730
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
Komen JJ; Pottegard A; Mantel-Teeuwisse AK; Forslund T; Hjemdahl P; Wettermark B; Hellfritzsch M; Hallas J; Olesen M; Bennie M; Mueller T; Voss A; Schink T; Haug U; Kollhorst B; Karlstad O; Kjerpeseth LJ; Klungel OH
Article: EUROPEAN HEART JOURNAL (EHJ) - CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(F11):f72-f80
Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
Komen JJ; Heerdink ER; Klungel OH; Mantel-Teeuwisse AK; Forslund T; Wettermark B; Hjemdahl P
Article: EUROPEAN HEART JOURNAL (EHJ) - CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(1):3-10
Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality
Komen JJ; Forslund T; Mantel-Teeuwisse AK; Klungel OH; von Euler M; Braunschweig F; Wallen H; Hjemdahl P
Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2020;13(9):925-934
Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet
Hoffmann M; Vander Stichele R; Bates DW; Bjorklund J; Alexander S; Andersson ML; Auraaen A; Bennie M; Dahl M-L; Eiermann B; Hackl W; Hammar T; Hjemdahl P; Koch S; Kunnamo I; Le Louet H; Panagiotis P; Raego L; Spedding M; Seidling HM; Demner-Fushman D; Gustafsson LL
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2020;107(1):287-294
Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and Bleeding
Komen JJ; Hjemdahl P; Mantel-Teeuwisse AK; Klungel OH; Wettermark B; Forslund T
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;296:1-7
Lipid levels achieved after a first myocardial infarction and the prediction of recurrent atherosclerotic cardiovascular disease
Ohm J; Hjemdahl P; Skoglund PH; Discacciati A; Sundstrom J; Hambraeus K; Jernberg T; Svensson P
Article: PLATELETS. 2019;30(8):975-981
Increased platelet reactivity and platelet?leukocyte aggregation after elective coronary bypass surgery
Ivert T; Dalen M; Ander C; Stalesen R; Lordkipanidze M; Hjemdahl P
Article: PLATELETS. 2019;30(3):348-355
Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus
Spectre G; Mobarrez F; Stalesen R; Ostenson C-G; Varon D; Wallen H; Hjemdahl P
Article: STROKE. 2018;49(9):2122-2128
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants The Stockholm Experience
Forslund T; Komen JJ; Andersen M; Wettermark B; von Euler M; Mantel-Teeuwisse AK; Braunschweig F; Hjemdahl P
Article: EUROPACE. 2018;20(3):420-428
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
Forslund T; Wettermark B; Andersen M; Hjemdahl P
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2017;120(8):1302-1308
Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non-Vitamin K Oral Anticoagulants
Loikas D; Forslund T; Wettermark B; Schenck-Gustafsson K; Hjemdahl P; von Euler M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2017;73(10):1315-1322
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
Komen J; Forslund T; Hjemdahl P; Wettermark B
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2017;83(3):642-652
Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis
Komen J; Forslund T; Hjemdahl P; Andersen M; Wettermark B
Article: THROMBOSIS AND HAEMOSTASIS. 2017;117(1):75-85
Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system
Agren A; Holmstrom M; Schmidt DE; Hosokawa K; Blomback M; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2017;149:64-69
Platelet function one and three months after coronary bypass surgery in relation to once or twice daily dosing of acetylsalicylic acid
Ivert T; Dalen M; Ander C; Stalesen R; Nasman P; Lordkipanidze M; Hjemdahl P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(6):944-952
Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease
Almquist T; Mobarrez F; Jacobson SH; Wallen H; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2016;141:93-97
Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels
Spectre G; Stalesen R; Ostenson C-G; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2016;72(3):329-338
Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
Forslund T; Wettermark B; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2015;136(1):154-160
From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples
Helin TA; Lemponen M; Hjemdahl P; Ronquist-Nii Y; Lassila R; Joutsi-Korhonen L
Article: THROMBOSIS RESEARCH. 2015;135(5):852-860
Does the Russell Viper Venomtime test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study
Douxfils J; Chatelain B; Hjemdahl P; Devalet B; Sennesael A-L; Wallemacq P; Ronquist-Nii Y; Pohanka A; Dogne J-M; Mullier F
Article: THROMBOSIS AND HAEMOSTASIS. 2015;113(4):862-869
Estimation of dabigatran plasma concentrations in the perioperative setting An ex vivo study using dedicated coagulation assays
Douxfils J; Lessire S; Dincq A-S; Hjemdahl P; Ronquist-Nii Y; Pohanka A; Gourdin M; Chatelain B; Dogne J-M; Mullier F
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2014;70(12):1477-1485
Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA₂DS₂VASc scores: experience from the Stockholm region
Forslund T; Wettermark B; Wandell P; von Euler M; Hasselstrom J; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2014;134(4):783-789
On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation
Skeppholm M; Hjemdahl P; Antovic JP; Muhrbeck J; Eintrei J; Ronquist-Nii Y; Pohanka A; Beck O; Malmstrom RE
Article: LAKARTIDNINGEN. 2014;111(22-23):980-981
[Swedish medical research does not need more control].
Andersén P; Bäckström T; Dahlquist G; Damber J-E; Engström-Laurent A; Gustafson Y; Hjemdahl P; Korsgren O; Olsson H; Wiberg M; Widmark A
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2014;44(3):276-284
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease
Almquist T; Jacobson SH; Mobarrez F; Nasman P; Hjemdahl P
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2013;170(2):208-214
Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: Experience from the Stockholm health care system
Forslund T; Wettermark B; Wandell P; von Euler M; Hasselstrom J; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(11):1875-1881
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
Antovic JP; Skeppholm M; Eintrei J; Boija EE; Soderblom L; Norberg E-M; Onelov L; Ronquist-Nii Y; Pohanka A; Beck O; Hjemdahl P; Malmstrom RE
Article: THROMBOSIS AND HAEMOSTASIS. 2013;110(3):543-549
Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate
Douxfils J; Dogne J-M; Mullier F; Chatelain B; Ronquist-Nii Y; Malmstrom RE; Hjemdahl P
Article: JOURNAL OF HYPERTENSION. 2013;31(8):1676-1682
Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension
Schwieler JH; Kahan T; Wallen NH; Nussberger J; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2013;43(2):141-151
Risk prediction in stable angina pectoris
Kahan T; Forslund L; Held C; Bjorkander I; Billing E; Eriksson SV; Nasman P; Rehnqvist N; Hjemdahl P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(9):3540-3546
Effects of lipid-lowering treatment on platelet reactivity and plateletleukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial
Almquist T; Jacobson SH; Lins P-E; Farndale RW; Hjemdahl P
Article: DIABETES. 2012;61(9):2380-2384
Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes
Spectre G; Ostenson C-G; Li N; Hjemdahl P
Article: THROMBOSIS AND HAEMOSTASIS. 2012;108(2):328-337
Platelets selectively enhance lymphocyte adhesion on subendothelial matrix under arterial flow conditions
Spectre G; Zhu L; Ersoy M; Hjemdahl P; Savion N; Varon D; Li N
Article: THROMBOSIS AND HAEMOSTASIS. 2011;106(3):491-499
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications
Spectre G; Arnetz L; Ostenson C-G; Brismar K; Li N; Hjemdahl P
Article: THROMBOSIS AND HAEMOSTASIS. 2011;106(2):353-362
Platelets regulate CD4⁺ T-cell differentiation via multiple chemokines in humans
Gerdes N; Zhu L; Ersoy M; Hermansson A; Hjemdahl P; Hu H; Hansson GK; Li N
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2011;108(4):224-233
The 'Wise List' - A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
Gustafsson LL; Wettermark B; Godman B; Andersen-Karlsson E; Bergman U; Hasselstrom J; Hensjo L-O; Hjemdahl P; Jagre I; Julander M; Ringertz B; Schmidt D; Sjoberg S; Sjoqvist F; Stiller C-O; Tornqvist E; Tryselius R; Vitols S; von Bahr C
Article: JOURNAL OF OBESITY. 2011;2011:459263-7
Usage, risk, and benefit of weight-loss drugs in primary care.
Forslund T; Raaschou P; Hjemdahl P; Krakau I; Wettermark B
Article: BMC HEALTH SERVICES RESEARCH. 2010;10:128
Forecasting drug utilization and expenditure in a metropolitan health region
Wettermark B; Persson ME; Wilking N; Kalin M; Korkmaz S; Hjemdahl P; Godman B; Petzold M; Gustafsson LL
Article: LAKARTIDNINGEN. 2010;107(13-14):910-913
[Anti-obesity agents do not seem to have any beneficial effects. Health centers prescribe preparations haphazardly, according to a medical records study].
Forslund T; Wettermark B; Raaschou P; Hjemdahl P; Krakau I
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2010;66(2):187-198
Regional variation and adherence to guidelines for drug treatment of asthma
Arnlind MH; Wettermark B; Nokela M; Hjemdahl P; Rehnberg C; Jonsson EW
Article: JOURNAL OF INTERNAL MEDICINE. 2009;266(5):457-466
Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment
Malmstrom RE; Orstergren J; Jorgensen L; Hjemdahl P
Article: LAKARTIDNINGEN. 2009;106(32-33):1992-1994
[SBU should investigate what is an evidence-based and cost-effective use of statins].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Article: HEART. 2009;95(15):1220-1222
Aspirin resistance testing not ready for "prime time''
Hjemdahl P
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2009;29(3):201-208
Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction
Bjorkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2009;7:26
Validation of the Clinical COPD Questionnaire (CCQ) in primary care
Stallberg B; Nokela M; Ehrs P-O; Hjemdal P; Jonsson EW
Article: THROMBOSIS AND HAEMOSTASIS. 2009;101(1):157-164
No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance
Malmstrom RE; Settergren M; Bohm F; Pernow J; Hjemdahl P
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2008;6(12):2186-2192
Platelet hyperprocoagulant activity in Type 2 diabetes mellitus: attenuation by glycoprotein IIb/IIIa inhibition
Razmara M; Hjemdahl P; Ostenson C-G; Li N
Article: LAKARTIDNINGEN. 2008;105(42):2917-2922
[A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment].
Gustafsson LL; Wettermark B; Kalin M; Korkmaz S; Persson ME; Almkvist H; Hjemdahl P; Julander M; Kristianson K; Ringertz B; Bergen-Dahl GT; Wilking N
Article: CIRCULATION. 2008;117(20):2591-2598
Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction - An individual patient meta-analysis: Meta-analysis research group in echocardiography acute myocardial infarction
Moller JE; Whalley GA; Dini FL; Doughty RN; Gamble GD; Klein AL; Quintana M; Yu CM
Article: CARDIOLOGY. 2008;111(2):126-133
Differential index:: A simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris
Bjoerkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
Article: LAKARTIDNINGEN. 2007;104(51-52):3879-3881
[Still questions around the slimming agent rimobant. Not approved in USA because of the risk of mental adverse effects].
Wettermark B; Raaschou P; Forslund T; Hjemdahl P
Article: THROMBOSIS AND HAEMOSTASIS. 2007;98(6):1316-1322
Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease
Perneby C; Wallen NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(2):148-158
Mechanisms of exercise-induced ST-segment depression in patients without typical angina pectoris
Sundkvist GMG; Hjemdahl P; Kahan T; Melcher A
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2007;27(2):407-413
Platelet activity, coagulation, and fibrinolysis during exercise in healthy males -: Effects of thrombin inhibition by argatroban and enoxaparin
Li N; He S; Blomback M; Hjemdahl P
Article: LAKARTIDNINGEN. 2007;104(5):310-311
[More evidence against COX-2 inhibitors. The risk of severe cardiovascular complications more and more obvious].
Hjemdahl P
Article: JOURNAL OF HYPERTENSION. 2007;25(1):169-175
Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity
Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
Article: DIABETES CARE. 2007;30(1):138-140
Food intake enhances thromboxane receptor-mediated platelet activation in type 2 diabetic patients but not in healthy subjects
Razmara M; Hjemdahl P; Yngen M; Ostenson C-G; Wallen NH; Li N
Article: JOURNAL OF INTERNAL MEDICINE. 2006;260(6):537-544
Prognostic implications of renal dysfunction in patients with stable angina pectoris
Almquist T; Forslund L; Rehnqvist N; Hjemdahl P
Article: GIORNALE ITALIANO DI CARDIOLOGIA. 2006;7(8):535-583
[Guidelines on the management of stable angina pectoris: executive summary].
Task Force per il Trattamento dell'Angina Pectoris; Fox K; Alonso Garcia MA; Ardissino D; Buszman P; Camici PG; Crea F; Daly C; De Backer G; Hjemdahl P; Lopez-Sendon J; Marco J; Morais J; Pepper J; Sechtem U; Simoons M; Thygesen K; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Osterspey A; Tamargo J; Zamorano JL; Andreotti F; Becher H; Dietz R; Fraser A; Gray H; Hernandez Antolin RA; Huber K; Kremastinos DT; Maseri A; Nesser H-J; Pasierski T; Sigwart U; Tubaro M; Weis M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2006;133(3):315-322
High glucose levels enhance platelet activation: involvement of multiple mechanisms
Sudic D; Razmara M; Forslund M; Ji QS; Hjemdahl P; Li NL
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2006;3(1):52-56
Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty.
Yngen M; Norhammar A; Hjemdahl P; Wallén NH
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2006;4(4):874-881
Platelet-lymphocyte conjugation differs between lymphocyte subpopulations
Li N; Ji Q; Hjemdahl P
Article: CHEST. 2006;129(4):925-932
Brief questionnaires for patient-reported outcomes in asthma -: Validation and usefulness in a primary care setting
Ehrs PO; Nokela A; Ställberg B; Hjemdahl P; Jonsson EW
Article: THROMBOSIS AND HAEMOSTASIS. 2006;95(4):652-658
Dose- and time-dependent antiplatelet effects of aspirin
Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
Article: HEART. 2006;92(2):177-182
Favourable long term prognosis in stable angina pectoris:: an extended follow up of the angina prognosis study in Stockholm (APSIS)
Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
Article: THROMBOSIS AND HAEMOSTASIS. 2006;95(1):85-93
Megakaryocytic cells synthesize and platelets secrete α5-laminins, and the endothelial laminin isoform laminin 10 (α5β1γ1) strongly promotes adhesion but not activation of platelets
Nigatu A; Sime W; Gorfu G; Geberhiwot T; Andurén I; Ingerpuu S; Doi M; Tryggvason K; Hjemdahl P; Patarroyo M
Article: DIABETIC MEDICINE. 2005;22(10):1326-1333
The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris
Held C; Björkander I; Forslund L; Rehnqvist N; Hjemdahl P
Article: LAKARTIDNINGEN. 2005;102(22):1751-1752
[LFN's evaluation of Inspra illustrates the need of drug committees!].
Malmström R; Hjemdahl P
Article: THROMBOSIS AND HAEMOSTASIS. 2005;93(5):922-926
Contrast medium attenuates platelet activation and plateletleukocyte cross-talk
Ji QS; Ghaly M; Hiemdahl P; Tornvall P; Li NL
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2005;98(3):493-499
Differential index, a novel graphical method for measurements of heart rate variability
Björkander I; Kahan T; Ericson M; Held C; Forslund L; Rehnqvist N; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2005;116(6):509-517
Marked increase of fibrin gel permeability with very low dose ASA treatment
Antovic A; Perneby C; Ekman GJ; Wallen HN; Hjemdahl P; Blombäck M; He S
Article: AMERICAN JOURNAL OF PHYSIOLOGY. HEART AND CIRCULATORY PHYSIOLOGY. 2004;287(5):H2309-H2315
Hemodynamic and sympathoadrenal responses to mental stress during nitric oxide synthesis inhibition
Lindqvist M; Melcher A; Hjemdahl P
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2004;96(2):183-189
Is left ventricular diastolic function an independent marker of prognosis after acute myocardial infarction?
Quintana M; Edner M; Kahan T; Hjemdahl P; Sollevi A; Rehnqvist N
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2004;805(1):87-91
Determination of perhexiline and hydroxyperhexiline in plasma by liquid chromatography-mass spectrometry
Beck O; Stephanson N; Morris RG; Sallustio BC; Hjemdahl P
Article: DIABETOLOGIA. 2004;47(5):853-859
Exercise-induced platelet and leucocyte activation is not enhanced in well-controlled Type 1 diabetes, despite increased activity at rest
Hu H; Johansson BL; Hjemdahl P; Li N
Article: DIABETOLOGIA. 2004;47(3):537-540
Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy:: evidence for platelet hyperactivity and chronic inflammation
Yngen M; Östenson CG; Hu H; Li N; Hjemdahl P; Wallén NH
Article: THROMBOSIS RESEARCH. 2004;114(4):235-243
Prothrombotic responses to exercise are little influenced by clopidogrel treatment
Perneby C; Wallén NH; Hu H; Li N; Hjemdahl P
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2004;2(1):58-64
Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus:: relationship to microangiopathy
Hu H; Li N; Yngen M; Östenson CG; Wallén NH; Hjemdahl P
Article: BLOOD COAGULATION AND FIBRINOLYSIS. 2003;14(8):749-753
No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction
Lagercrantz J; Bergman M; Lundman P; Tornvall P; Hjemdahl P; Hamsten A; Eriksson P
Article: THROMBOSIS AND HAEMOSTASIS. 2003;90(4):679-687
Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins
Hu H; Varon D; Hjemdahl P; Savion N; Schulman S; Li NL
Article: SHOCK. 2003;19(6):503-507
Adenosine treatment attenuates cytokine interleukin-6 responses to endotoxin challenge in healthy volunteers
Soop A; Johansson C; Hjemdahl P; Kristiansson M; Gyllenhammar H; Li NL; Sollevi A
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(1):1-9
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis -: Results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study
Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Kjerr ESAC; Näsman P
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2003;1(3):470-476
Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery
Li N; Astudillo R; Ivert T; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2003;111(3):165-170
Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry
Li NL; Hu H; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2002;107(5):209-215
Effects of insulin on platelet and leukocyte activity in whole blood
Hu H; Hjemdahl P; Li NL
Article: LAKARTIDNINGEN. 2002;99(21):2374-2375
[Strong lobbying for direct -to-consumer advertising of prescription drugs. Beneficial for the patient or for the increase of sales?].
Hjemdahl P
Article: HEART. 2002;87(5):415-422
Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris
Forslund L; Björkander I; Ericson M; Held C; Kahan T; Rehnqvist N; Hjemdahl P
Article: THROMBOSIS RESEARCH. 2002;106(2):91-95
Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type I diabetes mellitus patients and healthy subjects
Hu H; Li NL; Ekberg K; Johansson BL; Hjemdahl P
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2002;4(1):73-82
Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists
Persson H; Andréasson K; Kahan T; Eriksson SV; Tidgren B; Hjemdahl P; Hall C; Erhardt L
Article: CLINICAL SCIENCE. 2001;100(4):451-457
β₂-adrenoceptor desensitization in human alveolar macrophages induced by inhaled terbutaline in vivo is not counteracted by budesonide
Zetterlund A; Hjemdahl P; Larsson K
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2001;21(2):196-207
Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris:: influence of using modified limb electrodes
Malmqvist K; Kahan T; Eriksson S; Björkander I; Held C; Forslund L; Rehnqvist N; Hjemdahl P
Article: BLOOD COAGULATION AND FIBRINOLYSIS. 2001;12(2):109-116
Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus
Yngen M; Östenson CG; Li N; Hjemdahl P; Wallén NH
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2001;56(11):843-848
Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners
Nilsson G; Hjemdahl P; Hässler A; Vitols S; Wallén NH; Krakau I
Article: PSYCHOPHARMACOLOGY. 2001;153(2):231-237
Gender-related differences in response to placebo in benzodiazepine withdrawal: a single-blind pilot study
Saxon L; Hiltunen AJ; Hjemdahl P; Borg S
Article: EUROPEAN HEART JOURNAL. 2001;22(1):62-72
Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris
Held C; Hjemdahl P; Eriksson SV; Björkander I; Forslund L; Rehnqvist N
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2000;20(12):2702-2708
Platelet-leukocyte cross talk in whole blood
Li NL; Hu H; Lindqvist M; Wikström-Jonsson E; Goodall AH; Hjemdahl P
Article: THROMBOSIS AND HAEMOSTASIS. 2000;84(3):381-387
Multi-cellular activation in vivo by endotoxin in humans - Limited protection by adenosine infusion
Li NL; Soop A; Sollevi A; Hjemdahl P
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2000;65(1):57-65
A whole-blood flow cytometric assay for leukocyte CD11b expression using fluorescence signal triggering
Li NL; Halldén G; Hjemdahl P
Article: EUROPEAN HEART JOURNAL. 2000;21(11):901-910
Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil -: A report from The Angina Prognosis Study In Stockholm (APSIS)
Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
Article: JOURNAL OF INTERNAL MEDICINE. 2000;247(2):240-248
Psychosocial variables in relation to various risk factors in patients with stable angina pectoris
Billing E; Eriksson SV; Hjemdahl P; Rehnqvist N
Article: ATHEROSCLEROSIS. 2000;148(1):179-188
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris -: Results from the APSIS study
Held C; Hjemdahl P; Wallén NH; Björkander I; Forslund L; Wiman B; Rehnqvist N
Article: THROMBOSIS RESEARCH. 1999;96(6):427-436
Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B₂ in urine: Comparison with GC-MS
Perneby C; Granström E; Beck O; Fitzgerald D; Harhen B; Hjemdahl P
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1999;84(10):1151-1157
Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS])
Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1999;29(11):953-959
Inhaled nitric oxide does not influence bleeding time or platelet function in healthy volunteers
Albert J; Norman M; Wallén NH; Frostell C; Hjemdahl P
Article: CIRCULATION. 1999;100(13):1374-1379
Evidence for prothrombotic effects of exercise and limited protection by aspirin
Li NL; Wallén H; Hjemdahl P
Article: CLINICAL SCIENCE. 1999;97(3):345-353
Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers
Albert J; Wallén NH; Li NL; Frostell C; Hjemdahl P
Article: EUROPEAN HEART JOURNAL. 1999;20(14):1039-1043
Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction
Wallén NH; Held C; Rehnqvist N; Hjemdahl P
Article: CLINICAL SCIENCE. 1999;97(1):27-35
Activation of haemostasis by exercise, mental stress and adrenalin:: effects on platelet sensitivity to thrombin and thrombin generation
Wallén NH; Goodall AH; Li NL; Hjemdahl P
Article: PSYCHOPHARMACOLOGY. 1999;143(4):385-393
Rated well being in relation to plasma concentrations of I- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment
Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
Article: CYTOMETRY. 1999;35(2):154-161
Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering
Li NL; Goodall AH; Hjemdahl P
Article: JOURNAL OF HYPERTENSION. 1999;17(1):91-97
Flow dependence of forearm noradrenaline overflow, as assessed during mental stress and sodium nitroprusside infusion
Lindqvist M; Melcher A; Hjemdahl P
Article: BLOOD COAGULATION AND FIBRINOLYSIS. 1999;10(1):19-24
Acute effects of angiotensin II on fibrinolysis in healthy volunteers
Larsson PT; Schwieler JH; Wallén NH; Hjemdahl P
Article: EUROPEAN HEART JOURNAL. 1998;19(11):1666-1672
Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid
Williams S; Fatah K; Hjemdahl P; Blomback M
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1998;32(5):753-759
Adrenaline responsiveness in mild hypertension:: No evidence for altered β-adrenoceptor sensitivity
Kahan T; Hjemdahl P; Lindvall K; Östergren J; de Faire U
Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 1998;58(6):505-510
On the accurate measurement of serotonin in whole blood
Xiao R; Beck O; Hjemdahl P
Article: CLINICAL SCIENCE. 1998;94(6):663-670
Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans
Lördal M; Wallén H; Hjemdahl P; Beck O; Hellström PM
Article: THROMBOSIS RESEARCH. 1998;90(5):229-237
β-thromboglobulin in urine and plasma:: Influence of coronary risk factors
Mundal HH; Hjemdahl P; Urdal F; Kierulf P; Perneby C; Berg K; Gjesdal K
Article: AMERICAN JOURNAL OF HYPERTENSION. 1998;11(6):677-681
Acute effects of cigarette smoking on platelet function and plasma catecholamines in hypertensive and normotensive men
Mundal HH; Hjemdahl P; Gjesdal K
Article: EUROPEAN HEART JOURNAL. 1998;19(4):578-587
Ischaemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls - Gender differences and relationships to catecholamines
Forslund L; Hjemdahl P; Held C; Bjorkander I; Eriksson SV; Rehnqvist N
Article: ATHEROSCLEROSIS. 1998;137(1):107-113
Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation
Bröijersén A; Karpe F; Hamsten A; Goodall AH; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1998;28(3):235-242
Gemfibrozil-induced decrease in serum ubiquinone and α- and γ-tocopherol levels in men with combined hyperlipidaemia
Åberg F; Appelkvist EL; Bröijersen A; Eriksson M; Angelin B; Hjemdahl P; Dallner G
Article: THROMBOSIS AND HAEMOSTASIS. 1998;79(2):268-275
Platelet activity in vivo in hyperlipoproteinemia -: Importance of combined hyperlipidemia
Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Article: LAKARTIDNINGEN. 1998;95(5):407-408
[Accreditation should be discussed! Need for substance abuse testing at the workplace should be increased].
Beck O; Hjemdahl P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1997;99(4):808-816
A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates
Li N; Goodall AH; Hjemdahl P
Article: ATHEROSCLEROSIS. 1997;135(1):109-118
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol - Results from the Angina Prognosis Study in Stockholm (APSIS)
Held C; Hjemdahl P; Rehnqvist N; Bjorkander I; Forslund L; Brodin U; Berglund L; Angelin B
Article: JOURNAL OF HYPERTENSION. 1997;15(11):1317-1326
Differences between the effects of metoprolol and prazosin on the forearm vasculature in primary hypertension
Gretzer I; Hjemdahl P
Article: BLOOD COAGULATION AND FIBRINOLYSIS. 1997;8(8):517-524
Effects of serotonin on platelet activation in whole blood
Li N; Wallen NH; Ladjevardi M; Hjemdahl P
Article: ACTA PHYSIOLOGICA. 1997;161(2):135-140
Attenuation of forearm vasodilator responses to mental stress by regional beta-blockade, but not by atropine
Lindqvist M; Melcher A; Hjemdahl P
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 1997;41(9):1104-1113
Blockade of endogenous nitric oxide production results in moderate hypertension, reducing sympathetic activity and shortening bleeding time in healthy volunteers
Albert J; Schedin U; Lindqvist M; Melcher A; Hjemdahl P; Frostell C
Article: EUROPEAN HEART JOURNAL. 1997;18(6):911-918
Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls
Billing E; Hjemdahl P; Rehnqvist N
Article: PSYCHOPHARMACOLOGY. 1997;131(2):153-160
Effects of flumazenil in the treatment of benzodiazepine withdrawal - A double blind pilot study
Saxon L; Hjemdahl P; Hiltunen AJ; Borg S
Article: CIRCULATION. 1997;95(10):2380-2386
Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol - Results from the angina prognosis study in Stockholm
Held C; Hjemdahl P; Rehnqvist N; Wallen H; Bjorkander I; Eriksson SV; Forslund L; Wiman B
Article: EUROPEAN HEART JOURNAL. 1997;18(5):807-815
Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls
Wallen NH; Held C; Rehnqvist N; Hjemdahl P
Article: ACTA PHYSIOLOGICA. 1997;159(2):107-111
Plasma angiotensins and human forearm circulation: Effects of sympatho-adrenal activation
Kahan T; Lindqvist M; Nussberger J; Melcher A; Hjemdahl P
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 1997;17(2):273-278
No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia
Broijersen A; Eriksson M; Leijd B; Angelin P; Hjemdahl P
Article: EUROPEAN HEART JOURNAL. 1997;18:A36-A50
Calcium antagonist treatment, sympathetic activity and platelet function
Hjemdahl P; Wallen NH
Article: JOURNAL OF INTERNAL MEDICINE. 1997;241(1):59-69
Haemostatic markers, inflammatory parameters and lipids in male and female patients in the angina prognosis study in Stockholm (APSIS). A comparison with healthy controls
Held C; Hjemdahl P; Rehnqvist N; Wallen NH; Forslund L; Bjorkander I; Angelin B; Wiman B
Article: ACTA PHYSIOLOGICA. 1996;158(1):7-14
Sustained forearm vasodilation in humans during mental stress is not neurogenically mediated
Lindqvist M; Davidsson S; Hjemdahl P; Melcher A
Article: THROMBOSIS AND HAEMOSTASIS. 1996;76(2):171-176
Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII
Broijersen A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
Article: CLINICAL SCIENCE. 1996;91(2):225-231
Effects of inhaled nitric oxide compared with aspirin on platelet function in vivo in healthy subjects
Albert J; Wallen NH; Broijersen A; Frostell C; Hjemdahl P
Article: CARDIOLOGY. 1996;87(4):287-293
Age and gender differences in left ventricular function among patients with stable angina and a matched control group - A report from the Angina Prognosis Study in Stockholm
Eriksson SV; Bjorkander I; Held C; Hjemdahl P; Forslund L; Rehnqvist N
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 1996;16(4):511-516
Gemfibrozil treatment of combined hyperlipoproteinemia - No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels
Broijersen A; Eriksson M; Wiman B; Angelin B; Hjemdahl P
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1996;270(3):E393-E399
Forearm vasodilator mechanisms during mental stress: Possible roles of epinephrine and ANP
Lindqvist M; Kahan T; Melcher A; Bie P; Hjemdahl P
Article: JOURNAL OF HYPERTENSION. 1996;14(2):147-150
Biochemical assessment of sympathetic activity and prejunctional modulation of noradrenaline release in humans
Hjemdahl P; Friberg P
Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 1996;153(2):576-581
beta(2)-Agonist treatment reduces beta(2)-sensitivity in alveolar macrophages despite corticosteroid treatment
Hjemdahl P; Zetterlund A; Larsson K
Article: EUROPEAN HEART JOURNAL. 1996;17(1):76-81
Effects of metoprolol vs verapamil in patients with stable angina pectoris - The Angina Prognosis Study in Stockholm (APSIS)
Rehnqvist N; Hjemdahl P; Billing E; Bjorkander I; Eriksson SV; Forslund L; Held C; Nasman P; Wallen NH
Article: CARDIOLOGIA. 1995;40(12 Suppl 1):301
Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm.
Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén HN
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 1995;142(11):1157-1164
URINARY EXCRETIONS OF HIGH-MOLECULAR-WEIGHT BETA-THROMBOGLOBULIN AND ALBUMIN ARE INDEPENDENTLY ASSOCIATED WITH CORONARY HEART-DISEASE IN WOMEN, A NESTED CASE-CONTROL STUDY OF MIDDLE-AGED WOMEN IN THE DIAGNOSTISCH-ONDERZOEK-MAMMACARCINOOM (DOM) COHORT, UTRECHT, NETHERLANDS
GORGELS W; VANDERGRAAF Y; HJEMDAHL P; KORTLANDT W; COLLETTE HJA; ERKELENS DW; BANGA JD
Article: EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 1995;12(5):487-494
ADRENALINE, CYCLIC-AMP AND POTASSIUM DURING GENERAL-ANESTHESIA WITH AND WITHOUT EPIDURAL ANALGESIA
LOFGREN A; HJEMDAHL P; OLUND A; BERLIN T; HAHN RG
Article: CLINICAL SCIENCE. 1995;88(4):439-446
SYMPATHOADRENAL RESPONSES TO BRONCHOCONSTRICTION IN ASTHMA - AN INVASIVE AND KINETIC-STUDY OF PLASMA-CATECHOLAMINES
LARSSON K; CARLENS P; BEVEGARD S; HJEMDAHL P
Article: PSYCHOPHARMACOLOGY. 1995;118(2):122-126
SUBJECTIVE AND OBJECTIVE SYMPTOMS IN RELATION TO PLASMA METHADONE CONCENTRATION IN METHADONE PATIENTS
HILTUNEN AJ; LAFOLIE P; MARTEL J; OTTOSSON EC; BOREUS LO; BECK O; BORG S; HJEMDAHL P
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1995;47(5):411-416
ACUTE EFFECTS OF LOW-DOSE NICOTINE GUM ON PLATELET-FUNCTION IN NONSMOKING HYPERTENSIVE AND NORMOTENSIVE MEN
MUNDAL HH; HJEMDAHL P; GJESDAL K
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1995;75(1):1-6
PLATELET AGGREGABILITY IN-VIVO IS ATTENUATED BY VERAPAMIL BUT NOT BY METOPROLOL IN PATIENT WITH STABLE ANGINA-PECTORIS
WALLEN NH; HELD C; REHNQVIST N; HJEMDAHL P
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 1995;15(1):121-127
GEMFIBROZIL ENHANCES PLATELET ACTIVITY IN PATIENTS WITH COMBINED HYPERLIPOPROTEINEMIA
BROIJERSEN A; ERIKSSON M; ANGELIN B; HJEMDAHL P
Show more

All other publications

Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(4):557-574
Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials
Stiller C-O; Hjemdahl P
Letter: EUROPEAN HEART JOURNAL (EHJ) - CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(3):E31
Themultiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events? Response
Komen JJ; Forslund T; Mantel-Teeuwisse AK; Klungel OH; von Euler M; Braunschweig F; Wallen H; Hjemdahl P
Letter: THROMBOSIS RESEARCH. 2020;194:98-100
Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit
Agren A; Edgren G; Hjemdahl P; Gryfelt G; Ostlund A; Wikman A
Review: LAKARTIDNINGEN. 2018;115:FAH6
[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs].
Hjemdahl P; Braunschweig F; Holmström M; Johnsson H; von Euler M; Wallén H; Forslund T
Editorial comment: THE LANCET DIABETES AND ENDOCRINOLOGY. 2015;3(2):96-98
Can the metabolic syndrome be explained by a unifying concept?
Hjemdahl P
Review: LAKARTIDNINGEN. 2015;112:CZYS
[More with atrial fibrillation, anticoagulants since the coming of NOAK ].
Forslund T; von Euler M; Johnsson H; Holmström M; Wettermark B; Hjemdahl P
Meeting abstract: THROMBOSIS RESEARCH. 2014;133:S38-S39
IS THERE A ROLE FOR STANDARD THROMBIN TIME (TT) MEASUREMENTS FOR THE MONITORING OF LOW LEVELS OF DABIGATRAN?
Antovic JP; Berndtsson M; Malmstrom RE; Thalen S; Pohanka A; Norberg E-M; Ronquist Y; Hjemdahl P
Meeting abstract: BLOOD. 2013;122(21):3634
Is Dilute Russell's Viper Venom Time a Useful Assay To Monitor Patients Treated By Rivaroxaban Or Dabigatran Etexilate?
Douxfils J; Tamigniau A; Chatelain B; Devalet B; Wallemacq P; Hjemdahl P; Roenquist-Nii Y; Dogne J-M; Mullier F
Letter: JOURNAL OF HYPERTENSION. 2013;31(10):2103-2104
Platelet activation during exercise is not attenuated by inhibition of the renin-angiotensin system: the role of physical activity Reply
Kahan T; Schwieler JH; Wallen H; Nussberger J; Hjemdahl P
Letter: JOURNAL OF HYPERTENSION. 2013;31(9):1917
Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply
Kahan T; Schwieler JH; Wallen H; Nussberger J; Hjemdahl P
Letter: CIRCULATION. 2013;127(11):e505
Letter by Hjemdahl et al Regarding Article, "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"
Hjemdahl P; Johnsson H; Wallen NH
Review: LAKARTIDNINGEN. 2013;110(6):274-278
[Handling of platelet inhibitors in connection with surgery. Platelet function tests can contribute to wise decisions].
Dalén M; Van Der Linden J; Hjemdahl P; Ivert T
Other: LAKARTIDNINGEN. 2011;108(47):2444-2445
[Visions are good but the guidelines require evidence].
Hjemdahl P; Allhammar A; Eklund J; Forslund T; Hulting J; Kahan T; Martinsson A; Malmström R; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Letter: THROMBOSIS RESEARCH. 2011;127(6):605-606
Thromboxane metabolite excretion during pregnancy - influence of preeclampsia and aspirin treatment
Perneby C; Vahter M; Akesson A; Bremme K; Hjemdahl P
Letter: THROMBOSIS RESEARCH. 2010;125(5):473-474
Poor performance with a platelet counting technique to monitor clopidogrel inhibitory effects in the point-of-care setting
Malmstrom RE; Ostergren J; Jorgensen L; Hjemdahl P
Other: LAKARTIDNINGEN. 2009;106(40):2550-2551
[Lower and lower cholesterol targets increase adverse effects].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B; Forfattarna utgör Läkemedelssakkunnigas (Läksak) e; Stockholms Iäns landsting
Review: LAKARTIDNINGEN. 2009;106(23):1558-1562
[Fully possible to reduce the costs of hypertension treatment].
Wettermark B; Angman A; Hjemdahl P
Other: LAKARTIDNINGEN. 2009;106(1-2):52
[Rational introduction to new drugs requires both a health care and a community perspective].
Gustafsson LL; Wettermark B; Kalin M; Korkmaz S; Persson ME; Almkvist H; Hjemdahl P; Julander M; Kristianson K; Ringertz B; Bergendahl GT; Wiking N
Editorial comment: THROMBOSIS AND HAEMOSTASIS. 2008;100(4):517-518
Dyspnea and antiplatelet drugs: Little cause for concern with clopidogrel
Malmstrom RE; Hjemdahl P
Editorial comment: HEART. 2008;94(6):685-687
Should we monitor platelet function during antiplatelet therapy?
Hjemdahl P
Letter: THROMBOSIS AND HAEMOSTASIS. 2006;96(6):862-863
No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease
Wallen NH; Li N; Eriksson-Berg M; Landgren B-M; Schenck-Gustafsson K; Hjemdahl P
Review: REVISTA ESPANOLA DE CARDIOLOGIA. 2006;59(9):919-970
Guidelines on the management of stable angina pectoris:: Executive summary
Fox K; Alonso Garcia MA; Ardissino D; Buszman P; Camici PG; Crea F; Daly C; de Backer G; Hjemdahl P; Lopez-Sendon J; Marco J; Morais J; Pepper J; Sechtem U; Simoons M; Thygesen K
Review: EUROPEAN HEART JOURNAL. 2006;27(11):1341-1381
Guidelines on the management of stable angina pectoris: executive summary
Fox K; Angeles Alonso Garcia M; Ardissino D; Buszman P; Katowice; Camici PG; Crea F; Daly C; De Backer G; Ghent; Hjemdahl P; Lopez-Sendon J; Marco J; Morais J; Leiria; Pepper J; Sechtem U; Simoons M; Thygesen K; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstei K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Andreotti F; Becher H; Dietz R; Fraser A; Hernandez Antolin RA; Huber K; Kremastinos DT; Maseri A; Nesser H-J; Pasierski T; Sigwart U; Tubaro M; Weis M
Published conference paper: DIABETIC MEDICINE. 2006;23(2):134-140
Meal-induced platelet activation in Type 2 diabetes mellitus:: effects of treatment with repaglinide and glibenclamide
Yngen M; Östenson CG; Hjemdahl P; Wallén NH
Review: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2004;4(3):159-167
Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
Quintana M; Kahan T; Hjemdahl P
Editorial comment: JOURNAL OF HYPERTENSION. 2003;21(9):1615-1618
Endothelial COX-2 inhibition: possible relevance for hypertension and cardiovascular risk?
Stiller CO; Hjemdahl P
Editorial comment: CIRCULATION. 2002;106(21):2634-2636
Stress and the metabolic syndrome - An interesting but enigmatic association
Hjemdahl P
Review: LAKARTIDNINGEN. 2001;98(48):5472-5483
[Can we afford good cholesterol lowering therapy? Budgeting of statin costs versus medical needs in the county of Stockholm].
Wettermark B; Hjemdahl P
Published conference paper: THROMBOSIS RESEARCH. 2001;104(2):85-91
Insulin enhances platelet activation in vitro
Yngen M; Li NL; Hjemdahl P; Wallén NH
Editorial comment: EUROPEAN HEART JOURNAL. 2001;22(1):16-18
Smoking, nicotine and thrombotic risk - a role for platelet dependent thrombin generation?
Hjemdahl P
Letter: BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 1998;105(8):931-932
Pre-eclampsia: a state of sympathetic over-activity
Nisell H; Hjemdahl P
Published conference paper: JOURNAL OF ANALYTICAL TOXICOLOGY. 1997;21(7):554-557
The online screening technique for urinary benzodiazepines: Comparison with EMIT, FPIA, and GC-MS
Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
Meeting abstract: ATHEROSCLEROSIS. 1997;134(1-2):188
Platelet function in hypercholesterolemia - importance of combined hyperlipidemia
Broijersen A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Meeting abstract: ATHEROSCLEROSIS. 1997;134(1-2):190
Low or medium dose acetylsalicylic acid increases fibrin gel porosity is healthy adults
Fatah K; Williams S; Hjemdahl P; Blomback M
Review: AMERICAN JOURNAL OF CARDIOLOGY. 1996;77(16):6D-15D
Prognosis of patients with stable angina pectoris on antianginal drug therapy.
Hjemdahl P; Eriksson SV; Held C; Rehnqvist N
Other: EUROPEAN HEART JOURNAL. 1995;16:18
PREVENTION OF CARDIAC EVENTS IN PATIENTS WITH ANGINA-PECTORIS - RESULTS OF THE APSIS STUDY
REHNQVIST N; HJEMDAHL P; BILLING E; BJORKANDER I; ERIKSSON SV; FORSLUND L; HELD C; NASMAN P; WALLEN NH
Editorial comment: EUROPEAN HEART JOURNAL. 1995;16(8):1017-1019
PLATELET REACTIVITY, EXERCISE, AND STABLE CORONARY-ARTERY DISEASE
HJEMDAHL P
Published conference paper: CARDIOVASCULAR DRUGS AND THERAPY. 1995;9:493
PRIMARY PREVENTION IN PATIENTS WITH CORONARY HEART-DISEASE - THE APSIS STUDY
REHNQVIST N; HJEMDAHL P; BJORKANDER I; ERIKSSON SV; FORSLUND L; HELD C; WALLEN H; BILLING E
Show more

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI